Nervous system drug market to grow 3.2% to 2015 says new report
The report ‘Global Central Nervous System Drugs’ forecasts the nervous system drug market to grow at a CAGR of 3.2% to 2015. One of the key factors contributing to this market growth is the increasing size of aging population.
According to the report, the global EEG/EMG equipment market has been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market.
Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co.,Johnson &Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.
View the Report
Reportbuyer.com is the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.